LUNG
Price
$1.61
Change
-$0.03 (-1.83%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
357.24M
83 days until earnings call
XVIPF
Price
$20.54
Change
-$2.46 (-10.70%)
Updated
Aug 4 closing price
Capitalization
905.23M
Interact to see
Advertisement

LUNG vs XVIPF

Header iconLUNG vs XVIPF Comparison
Open Charts LUNG vs XVIPFBanner chart's image
Pulmonx
Price$1.61
Change-$0.03 (-1.83%)
Volume$17.35K
Capitalization357.24M
Xvivo Perfusion AB
Price$20.54
Change-$2.46 (-10.70%)
Volume$1.05K
Capitalization905.23M
LUNG vs XVIPF Comparison Chart in %
Loading...
LUNG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LUNG vs. XVIPF commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUNG is a Hold and XVIPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (LUNG: $1.61 vs. XVIPF: $20.54)
Brand notoriety: LUNG and XVIPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LUNG: 148% vs. XVIPF: 282%
Market capitalization -- LUNG: $357.24M vs. XVIPF: $905.23M
LUNG [@Medical Specialties] is valued at $357.24M. XVIPF’s [@Medical Specialties] market capitalization is $905.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUNG’s FA Score shows that 1 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).

  • LUNG’s FA Score: 1 green, 4 red.
  • XVIPF’s FA Score: 0 green, 5 red.
According to our system of comparison, LUNG is a better buy in the long-term than XVIPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUNG’s TA Score shows that 5 TA indicator(s) are bullish while XVIPF’s TA Score has 5 bullish TA indicator(s).

  • LUNG’s TA Score: 5 bullish, 5 bearish.
  • XVIPF’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, XVIPF is a better buy in the short-term than LUNG.

Price Growth

LUNG (@Medical Specialties) experienced а -48.89% price change this week, while XVIPF (@Medical Specialties) price change was -10.71% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.65%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was -3.32%.

Reported Earning Dates

LUNG is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XVIPF($905M) has a higher market cap than LUNG($357M). XVIPF YTD gains are higher at: -50.034 vs. LUNG (-76.289). XVIPF has higher annual earnings (EBITDA): 29.2M vs. LUNG (-55.49M). XVIPF has more cash in the bank: 171M vs. LUNG (117M). XVIPF has less debt than LUNG: XVIPF (27.6M) vs LUNG (41.4M). XVIPF has higher revenues than LUNG: XVIPF (524M) vs LUNG (68.7M).
LUNGXVIPFLUNG / XVIPF
Capitalization357M905M39%
EBITDA-55.49M29.2M-190%
Gain YTD-76.289-50.034152%
P/E RatioN/A344.83-
Revenue68.7M524M13%
Total Cash117M171M68%
Total Debt41.4M27.6M150%
FUNDAMENTALS RATINGS
XVIPF: Fundamental Ratings
XVIPF
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
83
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LUNGXVIPF
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
42%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
26%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
47%
Advances
ODDS (%)
Bullish Trend 16 days ago
76%
Bullish Trend 24 days ago
20%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
45%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LUNG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHLSX29.58N/A
N/A
Diamond Hill Long-Short I
NBRFX13.65N/A
N/A
Neuberger Berman Real Estate Tr
EGLCX10.34N/A
N/A
Eagle Energy Infrastructure C
JNBZX10.20N/A
N/A
JPMorgan Income Builder R6
MWMIX33.53-0.32
-0.95%
VanEck Morningstar Wide Moat I

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and USAQ have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and USAQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
N/A
USAQ - XVIPF
22%
Poorly correlated
N/A
VYCO - XVIPF
17%
Poorly correlated
N/A
ZTEK - XVIPF
9%
Poorly correlated
+1.94%
LUNG - XVIPF
6%
Poorly correlated
-1.83%
VPTDF - XVIPF
2%
Poorly correlated
N/A
More